Thomas A. McCarthy

Board Director

Director

Selective Insurance Group Inc Privia Health Group, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 1 buy · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€167k

▼ Sales (0 ops.)

—

Latest filing published 29 Jul 2025 for Selective Insurance Group INC, €167k. Read the official filing

Filing timeline

BuySale

Thomas A. McCarthy

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Thomas A. McCarthy: trading record in brief

Filings by Thomas A. McCarthy span 2 companies, the busiest being Selective Insurance Group Inc and Privia Health Group, Inc. We count 13 filings; the first trade dates from 30 April 2021 and the latest from 28 July 2025.

Every open-market trade on record is a purchase: 1 purchase worth €167k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants. 2025 to date brings 1 purchase and no sales.

Most recently, on 29 July 2025, the filings show an open-market purchase worth €167k in Selective Insurance Group Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.